Large-scale testing (Phase 3)Active Not RecruitingNCT05005975
What this trial is testing
Extension Study to Evaluate Safety and Tolerability of Oral Dersimelagon (MT-7117) in Subjects With Erythropoietic Protoporphyria (EPP) or X-Linked Protoporphyria (XLP)
Who this might be right for
EPPXLP
Tanabe Pharma America, Inc. 286